Steadfast and tenacious in our search for transformative therapies

petals image
green petal
Cells TARA-002


TARA-002 is the Company’s lead investigational cell therapy based on the broad immunopotentiator OK-432, which is approved in Japan and Taiwan for lymphatic malformations and multiple oncologic indications.

IV Choline Chloride for IFALD

An investigational phospholipid substrate replacement therapy for intestinal failure-associated liver disease (IFALD).
Cells IFALD1
Scroll to Top